SATSUMA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Conditions.

On May 11, 2021, Satsuma Pharmaceuticals, Inc. ("Satsuma" or the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2021, and its financial position as of March 31, 2021. The full text of the press release is furnished as Exhibit 99.1 hereto.

The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filings of the Company made under the Securities Act of 1933, as amended, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01 Financial Statements and Exhibits.

               Exhibit No.   Description

               99.1            Press Release dated May 11, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses